Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
769.50    4.50 (0.59%)
Bid:
770.00
Ask:
772.50
Spread: 2.50 (0.325%)
Market Cap: £886.26m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

New Mobile-Enabled healthcare platform

25 Aug 2015 08:00

RNS Number : 9365W
Kainos Group plc
25 August 2015
 

25 August 2015

Kainos Group plc

Kainos announces new Mobile-Enabled Healthcare platform to enhance patient care

 

New platform helps healthcare organisations provide better care using mobile applications on iPhone, iPad, iPod touch and Apple Watch

 

Belfast/London/Boston - August 25, 2015 - Kainos Group plc ("Kainos"), the UK-based provider of IT services, announces that Kainos Evolveâ has launched its Mobile-Enabled Healthcare platform, designed to give healthcare providers and carers secure access to patient information, regardless of location.

 

The new platform builds on the capabilities of Evolve's market-leading Electronic Medical Records (EMR) offering and enables new applications developed by Kainos, its partners and customers to store, access, process and share patient information securely. It supports easy integration with other clinical systems using healthcare interoperability standards and is accessed using mobile applications that have been developed exclusively for iOS and Apple Watch. The new platform is available on-premise, hosted or in the cloud and is designed to meet the requirements of an increasingly diverse healthcare market, from large hospitals through to community and emergency care providers.

 

Kainos' commitment to Apple was reinforced at Apple's July 21, Q3 2015 conference call, where Apple's CFO Luca Maestri confirmed that Apple is working with select mobility partners, including Kainos.

 

Brendan Mooney, Chief Executive Officer of Kainos, commented: "We are delighted to announce this new platform which will help deliver better healthcare outcomes at a lower cost. This is an important step for Evolve towards realising our vision to make healthcare delivery easier through technology, and we are pleased to be working with Apple at this time. As we grow our traditional customer base in the NHS and expand into new geographical markets, we see the opportunity to enable fundamental change in the delivery of care through this next generation of mobility."

 

Ends

 

For further information, please contact

 

Kainos

via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Brian Gannon, SVP Corporate Development

Investec Bank plc

+44 (0) 207 597 5970

Dominic Emery / Sebastian Lawrence

Patrick Robb / Matt Lewis

FTI Consulting LLP

+44 (0) 203 727 1000

Matt Dixon / Chris Lane

 

Notes to Editors

Kainos Group plc is a high-growth UK-based provider of IT services, consulting and software solutions, specialising across multiple sectors in the development of digital technology solutions. These include software design and agile software development, third-party software integration and implementation services, technology support services and related ancillary services such as project management.

 

Kainos operates through three divisions: Digital Services, which delivers full system developments of customised online digital solutions; Evolve, the UK market leader in the digitisation of patient notes in the Acute sector of the NHS; and Workday Implementation Services, the only boutique partner for Workday, Inc. headquartered in the UK, responsible for implementing Workday's innovative Software-as-a-Service platform for enterprise customers.

 

Headquartered in Belfast, Northern Ireland, Kainos employs approximately 750 staff across seven offices (Belfast, Derry, Dublin, London, Bristol, Gdansk and Boston). Kainos is listed on the Main Market of the London Stock Exchange (KNOS). For further information please visit the company website: https://www.kainos.com/ 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFSETTISFIE
Date   Source Headline
8th Jun 20264:04 pmRNSNotification of Transactions of Director/PDMR
4th Jun 202611:31 amRNSDirector / PDMR shareholdings
1st Jun 202610:27 amRNSTotal Voting Rights
18th May 20267:00 amRNSFull Year Results
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 202611:06 amRNSTotal Voting Rights
28th Apr 20261:38 pmRNSBoard and Board Committee Changes
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSYear-end Trading Update
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:22 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:10 pmRNSDirector Declaration
24th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:16 pmRNSNotification of Major Holdings
17th Mar 202611:28 amRNSDirector/PDMR shareholdings
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20264:58 pmRNSNotification of Transactions of Director/PDMR
12th Mar 20262:13 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.